FCM Permeabilization Buffer For permeabilizing fixed cells prior to IC staining with fluorochrome-conjugated antibodies.

FCM Permeabilization Buffer

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 151ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
FCM Permeabilization Buffer is rated 5.0 out of 5 by 2.
loading
5
2
4
0
3
0
2
0
1
0
Applicazione: FCM Permeabilization buffer (1X) is for permeabilizing fixed cells prior to IC staining with fluorochrome-conjugated antibodies
Informazioni supplementari: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
Solo per uso in Ricerca. Non previsto per Uso Diagnostico o Terapeutico.
* Vedere Certificato di Analisi per informazioni sul lotto specifico (incluso il contenuto d'acqua).
loading

FCM Permeabilization buffer (1X) is intended solely for permeabilizing fixed cells prior to intracellular staining with fluorochrome-conjugated antibodies. FCM Permeabilization buffer does not need to be present at any other steps following permeabilization.

Utilizzo :
Prior to use, FCM Permeabilization Buffer must be chilled to -20° C. FCM Permeabilization buffer (1X) may be stored long term at -20°C, 4°C or RT.
Stato fisico :
Liquid
CONSERVAZIONE :
Store at room temperature
Punto di ebollizione :
64° C
Solo per uso in Ricerca. Non previsto per Uso Diagnostico o Terapeutico.
Trasporto :
UN 1230, Class 3(6.1), Packing group II

Download SDS (MSDS)

CERTIFICATO DI ANALISI

Adobe Acrobat Reader necessario per una visualizzazione affidabile,
stampa e commenta sui documenti PDF

FCM Permeabilization Buffer  Citazioni prodotti

Vedi quanti altri hanno usato FCM Permeabilization Buffer. Clicca sulla voce per laccesso a PubMed .

Ciatazioni 1 a10 di 16 totali

PMID: # 31009502  Fathi, E.|Farahzadi, R.|Valipour, B.|Sanaat, Z.| et al. 2019. PLoS ONE. 14: e0215678.

PMID: # 31666661  Takeura, N.|Nakajima, H.|Watanabe, S.|Honjoh, K.|Takahashi, A.|Matsumine, A.| et al. 2019. Sci Rep. 9: 15656.

PMID: # 28474171  Okuma, KF.|Menuki, K.|Tsukamoto, M.|Tajima, T.|Fukuda, H.|Okada, Y.|Mori, T.|Tsuchiya, T.|Kawamoto, T.|Yoshida, Y.|Uchida, S.|Sakai, A.| et al. 2017. Calcif. Tissue Int. 101: 328-340.

PMID: # 28058860  Mehdizadeh, A. et al. 2017. Artif Cells Nanomed Biotechnol. 1-8.

PMID: # 28031237  Kim, BA.|Jee, HG.|Yi, JW.|Kim, SJ.|Chai, YJ.|Choi, JY.|Lee, KE.| et al. 2017. Cancer Genomics Proteomics. 14: 53-67.

PMID: # 27359377  Hoa, NT. et al. 2016. Expert Opin. Ther. Targets. 20: 1155-67.

PMID: # 26730203  2016. OncoTargets and therapy. 9: 49-59.

PMID: # 25511472  Wada, S. et al. 2015. Free Radic. Res. 49: 269-78.

PMID: # 25901196  Hoa, NT. et al. 2015. Am J Transl Res. 7: 271-84.

PMID: # 22778761  Romero, MM. et al. 2012. Clin. Dev. Immunol. 2012: -.

Ciatazioni 1 a10 di 16 totali
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 147ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 8ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;